MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation and Fugent LLC recently signed a supply agreement that establishes Promega as a provider of the leading transfection tool FuGENE® 6. This agreement ensures that researchers will continue to have access to the FuGENE® transfection reagents they have always used in their daily research. This expands on the existing Promega/Fugent agreement for supply of the FuGENE® HD Transfection reagent.
